EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Cellular DNA Damage Response in Cancer and Bacterial Infections: Current Progress, Challenges, and Opportunities

Ranxun Lin, Xu Zhang, Qinwei Zhu, Xuening Chen, Lin Dai, Longheng Li, Zuoan Li, Zhonghui Lin

Health and Metabolism · 2025

DOI: 10.53941/hm.2025.100010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health and Metabolism, 2025. Verfasst von Ranxun Lin und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective cancer treatment remains challenging due to the genomic instability of tumors and the frequent emergence of resistance. Traditional approaches such as radiotherapy, chemotherapy, and immunotherapy face limitations in addressing tumor heterogeneity and resistance mechanisms. Targeting the DNA damage response (DDR) pathway has emerged as an innovative strategy, either as monotherapy or in combination with conventional treatments. DDR-targeted therapies, including poly-ADP-ribose polymerase (PARP) inhibitors, have shown promise in reducing tumor growth and enhancing patient outcomes. Emerging targets such as ATM, ATR, CHK1/2, WRN, and PARG, coupled with cutting-edge technologies like CRISPR and proteolysis-targeting chimeras (PROTACs), have opened new avenues for precise and effective cancer treatment. Furthermore, combining DDR inhibitors with established therapies, such as immune checkpoint inhibitors, has demonstrated synergistic benefits, improving therapeutic efficacy and overcoming resistance. Beyond cancer, DDR inhibitors also offer the potential to combat bacterial pathogens by exploiting vulnerabilities in microbial DNA repair systems. This review focuses on the major advantages, challenges, and future directions of DDR-targeted therapies in cancer and bacterial infections. We also discuss the integration of these therapies with traditional approaches, highlighting their potential to enhance therapeutic outcomes across diverse applications.

Zitieren

APA

Lin, R., Zhang, X., Zhu, Q., Chen, X., Dai, L., Li, L., Li, Z., & Lin, Z. (2025). Targeting Cellular DNA Damage Response in Cancer and Bacterial Infections: Current Progress, Challenges, and Opportunities. Health and Metabolism. https://doi.org/10.53941/hm.2025.100010

Vancouver

Lin R, Zhang X, Zhu Q, Chen X, Dai L, Li L, et al. Targeting Cellular DNA Damage Response in Cancer and Bacterial Infections: Current Progress, Challenges, and Opportunities. Health and Metabolism. 2025. doi:10.53941/hm.2025.100010

BibTeX
@article{Lin2025,
  author = {Lin, Ranxun and Zhang, Xu and Zhu, Qinwei and Chen, Xuening and Dai, Lin and Li, Longheng and Li, Zuoan and Lin, Zhonghui},
  title = {Targeting Cellular DNA Damage Response in Cancer and Bacterial Infections: Current Progress, Challenges, and Opportunities},
  journal = {Health and Metabolism},
  year = {2025},
  doi = {10.53941/hm.2025.100010}
}
Kostenlos starten →